๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous Squamous Cell Carcinoma of the Head and Neck

Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites๐Ÿ“ Maastricht๐Ÿ“ Amsterdam๐Ÿ“ Amsterdam The Netherlands Cancer Institute ยท Tests: Nivolumab, Ipilumimab TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resโ€ฆ A Study of IDP-001 in Advanced or Metastatic Solid Tumors NCT07602842Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ Indianapolis InduPro, Inc. ยท Tests: IDP-001 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites๐Ÿ“ Kingswood๐Ÿ“ Wollongong๐Ÿ“ Southport Radiopharm Theranostics, Ltd ยท Tests: 177Lu-RAD204 IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site๐Ÿ“ Nashville Eben Rosenthal ยท Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record Rโ€ฆ A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ New Haven GV20 Therapeutics ยท Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDAยฎ], GV20-0251 and Pembrolizumab [KEYTRUDAยฎ] Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer NCT06532279Phase 2153 sites๐Ÿ“ Gilbert๐Ÿ“ Peoria๐Ÿ“ Phoenix NRG Oncology ยท Tests: Best Practice, Biospecimen Collection, Cisplatin, Computed Tomography, Image Guided Radiation Therapy Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites๐Ÿ“ Grenoble๐Ÿ“ Lyon Alpha Tau Medical LTD. ยท Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy Thermotherapy in Addition to SOC Palliative Radiotherapy NCT06659146NA2 sites๐Ÿ“ London๐Ÿ“ London King's College London ยท Tests: Superficial hyperthermia ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites๐Ÿ“ Birmingham๐Ÿ“ Chandler๐Ÿ“ Hot Springs Guardant Health, Inc. ยท Tests: Guardant Reveal Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site๐Ÿ“ Angers University Hospital, Angers ยท Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) A Study of VET3-TGI in Patients With Solid Tumors NCT06444815Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Miami KaliVir Immunotherapeutics ยท Tests: VET3-TGI, Atezolizumab Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors NCT04429542Phase 121 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Bicara Therapeutics ยท Tests: BCA101, Pembrolizumab Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: MQ719, Pembrolizumab Intratumoral N17350 in Advanced Solid Tumors NCT07339176Phase 1, Phase 29 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ San Diego Onchilles Pharma Inc ยท Tests: N17350 Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma NCT05025813Phase 23 sites๐Ÿ“ Camperdown๐Ÿ“ Herston๐Ÿ“ Woolloongabba Queensland Health ยท Tests: Pembrolizumab Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma NCT07156227Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Pittsburgh National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Camonsertib, Computed Tomography, Positron Emission Tomography, Stereotactic Body Radiation Theโ€ฆ Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer NCT07094685Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab, Magnetic Resonance Imaging Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation NCT06662058NA1 site๐Ÿ“ Atlanta Emory University ยท Tests: Audiometric Test, Audiometric Test, Audiometric Test, Interview Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and Neck NCT07869823EARLY Phase 11 site๐Ÿ“ St Louis Vanderbilt-Ingram Cancer Center ยท Tests: Cemiplimab, Radiation Therapy Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. NCT03889899NA1 site๐Ÿ“ Haifa Alpha Tau Medical LTD. ยท Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer NCT06992427Phase 3212 sites๐Ÿ“ Gilbert๐Ÿ“ Peoria๐Ÿ“ Phoenix Alliance for Clinical Trials in Oncology ยท Tests: Gabapentin, Placebo, Chemotheraphy, Radiation Therapy, Analgesic Agent A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827Phase 1, Phase 220 sites๐Ÿ“ Sydney๐Ÿ“ Westmead๐Ÿ“ Brisbane Hummingbird Bioscience ยท Tests: HMBD-001, Docetaxel, Cetuximab A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Stanford Anusha Kalbasi ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites๐Ÿ“ Anchorage๐Ÿ“ Fayetteville๐Ÿ“ Rogers Seagen, a wholly owned subsidiary of Pfizer ยท Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment NCT06589804Phase 3202 sites๐Ÿ“ Little Rock๐Ÿ“ Marysville๐Ÿ“ Palo Alto National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Cetuximab, Computed Tomography, Magnetic Resonance Imaging, Pembrolizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy